Chemoinformaics analysis of gamma-Glutamylaspartic acid
Molecular Weight | 262.218 | nRot | 8 |
Heavy Atom Molecular Weight | 248.106 | nRig | 4 |
Exact Molecular Weight | 262.08 | nRing | 0 |
Solubility: LogS | -1.299 | nHRing | 0 |
Solubility: LogP | -4.188 | No. of Aliphatic Rings | 0 |
Acid Count | 3 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 32.1791 |
nHD | 5 | BPOL | 17.5169 |
QED | 0.342 |
Synth | 2.763 |
Natural Product Likeliness | 0.654 |
NR-PPAR-gamma | 0.028 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.124 |
HIA | 0.077 |
CACO-2 | -6.57 |
MDCK | 0.00370073 |
BBB | 0.101 |
PPB | 0.140482 |
VDSS | 0.463 |
FU | 0.724019 |
CYP1A2-inh | 0 |
CYP1A2-sub | 0.008 |
CYP2c19-inh | 0.03 |
CYP2c19-sub | 0.026 |
CYP2c9-inh | 0.055 |
CYP2c9-sub | 0.599 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.091 |
CYP3a4-inh | 0.02 |
CYP3a4-sub | 0.001 |
CL | 2.727 |
T12 | 0.709 |
hERG | 0.006 |
Ames | 0.018 |
ROA | 0.002 |
SkinSen | 0.138 |
Carcinogencity | 0.022 |
EI | 0.085 |
Respiratory | 0.024 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.732587 |